Skip to main content

Postdoc Portrait: Christina Kiessling

This postdoc works to decode virulence regulation in multidrug-resistant bacteria to inform next-generation antimicrobial development.

Brought to you byThe Scientist
| 2 min read
A picture of Christina Kiessling, a postdoc at Emory University School of Medicine.
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Q | Write a brief introduction to yourself including the lab you work in and your research background.

My name is Christina Kiessling and I am a postdoctoral researcher at Emory University School of Medicine. In the Rather lab, we have the goal to identify (1) novel antimicrobials against multidrug-resistant Acinetobacter baumannii, (2) genetic vulnerabilities resulting as a byproduct of multidrug resistance, and (3) the regulatory mechanism that facilitates A. baumannii's switching from virulent to avirulent subpopulations.

Q | How did you first get interested in science and/or your field of research?

I was lucky to have a very passionate professor in junior year who got me excited about molecular biology. I felt very passionate about studying biology at the smallest level of organization, meaning at a molecular level. I started my PhD in an environmental microbiology lab due to a combination of factors, but luckily for me, I realized I was in the right place because I enjoyed working with bacteria. For my postdoc, I had two goals: learn more and switch specialties within microbiology. I am very thankful that my current PI gave me the chance to work in clinical microbiology.

Q | Tell us about your favorite research project you’re working on.

Because conventional antibiotics don’t work against Acinetobacter baumannii, we screened the U.S. Food and Drug Administration (FDA)-approved drug library in the hopes of identifying drugs that would show activity against Acinetobacter baumannii. These drugs are already being used for a variety of conditions, but we "repurposed" them as antibiotics. Our screen revealed a number of promising drugs whose antibiotic properties we are now studying in detail.

Continue reading below...

Like this story? Sign up for FREE Microbiology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

Q | What has been the most exciting part of your scientific career/journey so far?

I am excited about the fact that during my PhD I studied environmental microbiology with a focus on anaerobic bioremediation of crude oil derived contaminants, and that now, I get to study regulatory mechanisms of pathogenesis as well as promising novel antibiotic agents in Acinetobacter baumannii. I feel very lucky that I get to experience two very different niches of microbiology and believe it will make me a better scientist in the long run.

Q | If you could be a laboratory instrument, which one would you be and why?

I want to be a thermocycler. Thermocyclers are the most essential piece of equipment of modern molecular biology, in my opinion. Without them, nothing would be possible. I am also impressed that before they were invented, scientists manually moved samples through a series of water baths to accomplish PCR.

Are you a researcher who would like to be featured in the “Postdoc Portraits” series? Send in your application here.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo